Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro

Journal of Bone and Mineral Research

Volumn 13, Issue 7, 1998, Pages 1101-1111

  Rittling, Susan R ^a   Matsumoto, Hiroko N ^b   Mckee, Marc D ^c   Nanci, Antonio ^c   An, Xiao Rong ^d   Novick, Kristine E ^a   Kowalski, Aaron J ^a   Noda, Masaki ^b   Denhardt, David T ^a  

^a RUTGERS UNIVERSITY   (United States)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOPONTIN;

AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; BONE STRUCTURE; CELL CULTURE; CELL DIFFERENTIATION; IN VITRO STUDY; MESSENGER RNA SYNTHESIS; MOUSE; NONHUMAN; OSSIFICATION;

ANIMALS; BONE AND BONES; BONE DENSITY; BONE DEVELOPMENT; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED BALB C; OSTEOBLASTS; OSTEOCLASTS; OSTEOPONTIN; RNA, MESSENGER; SIALOGLYCOPROTEINS; SPLEEN; TOOTH;

EID: 0031836772     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1998.13.7.1101     Document Type: Article

References (67)

1. Denhardt DT, Guo X 1993 Osteopontin: A protein with diverse functions. FASEB J 7:1475-1482.
2. Giachelli CM, Schwartz SM, Liaw L 1995 Molecular and cellular biology of osteopontin: Potential role in cardiovascular disease. Trends Cardiovasc Med 5:88-95.
3. Butler WT, Ridall AL, McKee MD 1996 Osteopontin. In: Bilezekian, JP, Raisz, LG, Rodan, GA (eds.) Principles of Bone Biology. Academic Press, San Diego, CA, U.S.A., pp. 167-181.
4. Reinholt FP, Hultenby K, Oldberg C, Heinegård D 1990 Osteopontin - A possible anchor of osteoclasts to bone. Proc Natl Acad Sci USA 8:4473-4475.
5. McKee MD, Nanci A 1995 Osteopontin and the bone remodeling sequence: Colloidal-gold immunocytochemistry of an interfacial extracellular matrix protein. Ann NY Acad Sci 760: 177-189.
6. Sørensen ES, Højrup P, Petersen TE 1995 Post-translational modification of bovine osteopontin: Identification of twentyeight phosphorylation and three O-glycosylation sites. Protein Sci 4:2040-2049.
7. Patarca R, Saavedra RA, Cantor H 1993 Molecular and cellular basis of genetic resistance to bacterial infection: The role of the early T-lymphocyte activation-1/osteopontin gene. Crit Rev Immunol 13:225-246.
8. Smith JH, Denhardt DT 1987 Molecular cloning of a tumor promoter-inducible mRNA found in JB6 mouse epidermal cells: Induction is stable at high, but not at low, cell densities. J Cell Biochem 34:13-22.
9. Craig AM, Bowden GT, Chambers AF, Spearman MA, Green-berg AH, Wright JA, McLeod M, Denhardt DT 1990 Secreted phosphoprotein mRNA is induced during multi-stage carcinogenesis in mouse skin and correlates with the metastatic potential of murine fibroblasts. Int J Cancer 46:133-137.
10. Gardner HAR, Berse B, Senger DF 1994 Specific reduction in osteopontin synthesis by antisense RNA inhibits the tumorigenicity of transformed Rat1 fibroblasts. Oncogene 9:2321-2326.
11. Feng B, Rollo EE, Denhardt DT 1995 Osteopontin (OPN) may facilitate metastasis by protecting cells from macrophage NO-mediated cytotoxicity: Evidence from cell lines down-regulated for OPN expression by a targeted ribozyme. Clin Exp Metastasis 13:453-462.
12. Oates AJ, Barraclough R, Rudland PS 1996 The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model. Oncogene 13:97-104.
13. v-subunit. Endocrinology 137:2432-2440.
14. Chellaiah M, Hruska K 1996 Osteopontin stimulates gelsolin-associated phosphoinositide levels and phosphatidylinositol triphosphate-hydroxyl kinase. Mol Biol Cell 7:743-753.
15. Hwang S-M, Lopez CA, Heck DE, Gardner CR, Laskin DL, Laskin JD, Denhardt DT 1994 Osteopontin inhibits induction of nitric oxide synthase activity by inflammatory mediators in mouse kidney epithelial cells. J Biol Chem 269:711-715.
16. Rollo EE, Denhardt DT 1996 Differential effects of osteopontin on the cytotoxic activity of macrophages from young and old mice. Immunology 88:642-647.
17. Rollo EE, Laskin DL, Denhardt DT 1996 Osteopontin inhibits nitric oxide production and cytotoxicity by activated RAW-264.7 macrophages. J Leukoc Biol 60:397-404.
18. Denhardt DT, Chambers AF 1994 Overcoming obstacles to metastasis-Defenses against host defenses: Osteopontin (OPN) as a shield against attack by cytotoxic host cells. J Cell Biochem 56:48-51.
19. Carlson I, Tognazzi K, Manseau EJ, Dvorak HF, Brown LF 1997 Osteopontin is strongly expressed by histiocytes in granulomas of diverse etiology. Lab Invest 77:103-108.
20. Nau GJ, Guilfoile P, Chupp GF, Berman JS, Kim SJ, Kornfeld H, Young RA 1997 A chemoattractant cytokine associated with granulomas in tuberculosis and silicosis. Proc Natl Acad Sci USA 94:6414-6419.
21. Liaw L, Almeida M, Hart CE, Schwartz SM, Giachelli CM 1994 Osteopontin promotes vascular cell adhesion and spreading and is chemotactic for smooth muscle cells in vitro. Citc Res 74:214-224.
22. 3 integrin, Osteopontin, and thrombin. Am J Pathol 149: 293-305.
23. Singh RP, Patarca R, Schwartz J, Singh P, Cantor H 1990 Definition of a specific interaction between the early T lymphocyte activation 1 (ETA-1) protein and murine macrophages in vitro and its effect upon macrophages in vivo. J Exp Med 171:1931-1942.
24. Weber GF, Ashkar S, Glimcher MJ, Cantor H 1996 Receptor-ligand interaction between CD-44 and Osteopontin (ETA-1). Science 271:509-512.
25. Giachelli CM, Pichier R, Lombardi D, Denhardt DT, Alpers CE, Schwartz SM, Johnson RJ 1994 Osteopontin expression in angiotcnsin II-induced tubulointerstitial nephritis. Kidney Int 45:515-524.
26. Pichler R, Giachelli CM, Lombardi D, Pippin J, Gordon K, Alpers CE, Schwartz SM, Johnson RJ 1994 Tubulointerstitial disease in glomerulonephritis: Potential role of osteopontin (uropontin). Am J Path 144:915-926.
27. Diamond JR, Kees-Folts D, Ricardo SD, Pruznak A, Eufemio M 1995 Early and persistent up-regulated expression of renal cortical osteopontin in experimental hydronephrosis. Am J Pathol 146:1455-1466.
28. Lopez CA, Hoyer JR, Wilson PD, Waterhouse P, Denhardt DT 1993 Heterogeneity of osteopontin expression among nephrons in mouse kidney and enhanced expression in sclerotic glomeruli. Lab Invest 69:355-363.
29. Kohri K, Nomura S, Kitamura Y, Nagata T, Yoshioka K, Iguchi T, Yamate T, Umekawa Y, Suzuki H, Sinohara H, Kurita T 1993 Structure and expression of the mRNA encoding urinary stone protein (osteopontin). J Biol Chem 258:15180-15184.
30. McKee MD, Nanci A, Khan SR 1995 Ultrastructural immuno-detection of osteopontin and osteocalcin as major matrix components of renal calculi. J Bone Miner Res 10:1913-1929.
31. McKee MD, Nanci A 1996 Osteopontin at mineralized tissue interfaces in bone, teeth, and osseointegrated implants: Ultra-structural distribution and implications for mineralized tissue formation, turnover, and repair. Microsc Res Tech 33:141-164.
32. McKee MD, Nanci A 1996 Secretion of osteopontin by macrophages and its accumulation at tissue surfaces during wound healing in mineralized tissues: A potential requirement for macrophage adhesion and phagocytosis. Anat Rec 245:394-409.
33. McKee MD, Nanci A 1996 Osteopontin: An interfacial extracellular matrix protein in mineralized tissues. Connect Tissue Res 35:197-205.
34. Boskey AL, Maresca M, Ullrich W, Doty SB, Butler WT, Prince CW 1993 Osteopontin-hydroxyapatite interactions in vitro: Inhibition of hydroxyapatite formation and growth in a gelatin-gel. Bone Miner 22:147-159.
35. Hunter GK 1996 Interfacial aspects of biomineralization. Curr Opin Solid State Mater Sei 1:430-435.
36. Hunter GK, Hauschka PV, Poole AR, Rosenberg LC, Goldberg HA 1996 Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem J 317:59-64.
37. Craig AM, Denhardt DT 1991 The murine gene encoding secreted phosphoprotein 1 (osteopontin): Promoter structure, activity, and induction in vivo by estrogen and progesterone. Gene 100:163-171.
38. Thomas KR, Capecchi MR 1987 Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 51: 503-512.
39. Mansour SL, Thomas KR, Capecchi MR 1988 Disruption of the proto-oncogene int-2 in mouse embryo-derived cells: A general strategy for targeting mutations to non-selectable genes. Nature (Lond) 336:348-352.
40. Soriano P, Montgomery C, Geske R, Bradley A 1991 Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64:693-702.
41. Prince CW, Oosawa T, Butler WT, Tomana M, Bhown AS, Bhown M, Schrohenloher RE 1987 Isolation, characterization, and biosynthesis of a phosphorylated glycoprotein from rat bone. J Biol Chem 262:2900-2907.
42. Rittling SR, Novick KE 1997 Osteopontin expression in mammary gland development and tumorigenesis. Cell Growth Differ 8:1061-1069.
43. Fisher LW, Hawkins GR, Tuross N, Termine JD 1987 Purification and partial characterization of small proteoglycans I and II, bone sialoproteins I and II, and osteonectin from the mineral compartment of developing human bone. J Biol Chem 262:9702-9708.
44. Bendayan M 1995 Colloidal gold post-embedding immunocytochemistry. Prog Histochem Cytochem 29:1-159.
45. Takahashi N, Akatsu A, Udagawa N, Sasaki T, Yamaguchi A, Moseley J, Martin TJ, Suda T 1988 Osteoblastic cells are involved in osteoclast formation. Endocrinology 123:2600-2602.
46. Udagawa N, Takahashi N, Akatsu T, Sasaki T, Yamaguchi A, Kodama H, Martin TJ, Suda T 1989 The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with spleen cells. Endocrinology 125:1805-1813.
47. Matsumoto HN, Tamura M, Denhardt DT, Obinata M, Noda M 1995 Establishment and characterization of bone marrow stromal cell lines that support osteoclastogenesis. Endocrinology 136:4084-4091.
48. Liaw L, Birk DE, Ballas CB, Whitsitt JS, Davidson JS, Hogan BLM 1998 Altered wound healing in mice lacking a functional osteopontin gene (sppl). J Clin Invest 101:1468-1478.
49. Franzen A, Heinegård D 1985 Isolation and characterization of two sialoproteins present only in bone calcified matrix. Biochem J 232:715-724.
50. Akatsu T, Tamura T, Takahashi N, Udagawa N, Tanaka S, Sasaki T, Yagamushi A, Nagata N, Suda T 1992 Preparation and characterization of a mouse osteoclast-like multinunucleated cell population. J Bone Miner Res 7:1297-1306.
51. Grigoriadis AE, Wang ZQ, Cecchini MG, Hofstetter W, Felix R, Fleisch HA, Wagner EF 1994 c-fos: A key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266:443-448.
52. Butler WT 1995 Structural and functional domains of osteopontin. Ann NY Acad Sci 760:6-11.
53. Brown LF, Van Berse B, de Water LI, Papadopoulos-Sergiou A, Peruzzi CA, Manseau EJ, Dvorak HR, Senger DR 1992 Expression and distribution of osteopontin in human tissues; widespread association with luminal epithelial surfaces. Mol Biol Cell 3:1169-1180.
54. Chen J, Singh K, Mukherjee BB, Sodek J 1993 Developmental expression of osteopontin (OPN) mRNA in rat tissues: Evidence for a role for OPN in bone formation and resorption. Matrix 13:113-120.
55. Shiraga H, Min W, VanDusen WJ, Clayman MD, Miner D, Terrell CH, Sherbotie JR, Foreman JW, Przysiecki C, Neilson EG, Hoyer JR 1992 Inhibition of calcium oxalate crystal growth in vitro by uropontin, a new member of the aspartic-acid rich protein superfamily. Proc Natl Acad Sci USA 89:426-430.
56. Worcester EM, Blumenthal SS, Beshensky AM, Lewand DL 1992 The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin. J Bone Miner Res 7:1029-1036.
57. Zheng X, Saunders TL, Camper SA, Samuelson LC, Ginsburg D 1995 Vitronectin is not essential for normal mammalian development and fertility. Proc Natl Acad Sci USA 92:12426-12430.
58. Saga Y, Yagi T, Ikawa Y, Sakakura T, Aizawa S 1992 Mice develop normally without tenascin. Genes Dev 6:1821-1831.
59. Goldberg HA, Hunter GK 1995 The inhibitory activity of osteopontin on hydroxyapatite formation in vitro. Ann NY Acad Sci 760:305-308.
60. Moradian-Oldak J, Frolow F, Addadi L, Weiner S 1992 Interactions between acidic matrix macromolecules and calcium phosphate ester crystals: relevance to carbonate apatite formation in biomineralization. Proc R Soc Lond (Biol) 24:47-55.
61. Aizenberg J, Hanson J, Ilan M, Leiserowitz L, Koetzle TF, Addadi L, Weiner S 1995 Morphogenesis of calcitic sponge spicules: A role for specialized proteins interacting with growing crystals. FASEB J 9:262-268.
62. Yamate T, Mocharla H, Taguchi Y, Igietseme JU, Manolagas SC, Abe E 1997 Osteopontin expression by osteoclast and osteoblast progenitors in the murine bone marrow: Demonstration of its requirement for osteoclastogenesis and its increase after ovariectomy. Endocrinology 138:3047-3055.
63. Young BA, Burdmann EA, Johnson RJ, Alpers CE, Giachelli CM, Eng E, Andoh T, Bennett WM, Couser WG 1995 Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity. Kidney Int 48:439-438.
64. Lampe MA, Patarca R, Iregui MV, Cantor H 1991 Polyclonal B-cell activation by the Eta-1 cytokine and the development of autoimmune disease. J Immunol 147:2902-2906.
65. Giachelli CM, Lombardi D, Johnson RJ, Murry CE, Almeida M 1998 Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 152:353-358.
66. Rodan G 1995 Osteopontin overview. Ann NY Acad Sci 760: 1-5.
67. Sørensen ES, Rasmussen LK, Møller L, Jensen PH, Højrup P, Petersen TE 1994 Localization of transglutaminase-reactive glutamine residues in bovine osteopontin. Biochem J 304:13-16.